About the Calcium pyrophosphate deposition (CPPD) Working Group
Calcium pyrophosphate deposition (CPPD) is due to calcium crystals depositing within joints. CPPD can lead to different forms of arthritis including an acute form (commonly known as pseudogout), where people experience acute episodes of joint pain and swelling, or a chronic form, where symptoms can last for a longer period. People with osteoarthritis can also develop CPPD. Not all people with calcium crystals in their joints experience symptoms.
Although CPPD is common, there has been very little research into this condition. Currently, there is no universally accepted way of reporting outcomes in studies of this condition.
Nicola Dalbeth
Co-Chair
Sara Tedeschi
Co-Chair
Abhishek Abhishek
Co-Chair
Yiling Zhang
Fellow
David Grossberg
Patient Research Partner
Owen Hensey
Patient Research Partner
Introduction To Calcium Pyrophosphate Deposition (CPPD)
RECENT WORKING GROUP PUBLICATIONS
Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition(CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition(CPPD) disease: A framework paper by the OMERACT CPPD working group